April 30, 2026
A creditor of three ProPhase Labs entities that provided COVID-19 testing services objected to the debtors' motion to extend the exclusive right to file a Chapter 11 reorganization plan, arguing that the debtors have made no meaningful progress in their bankruptcy cases.
September 23, 2025
A CVS Health pharmacy services subsidiary entered bankruptcy after a court entered a $949 million judgment against it. Biotechnology company ProPhase put three of its COVID-19 laboratory testing subsidiaries in Chapter 11. And a California cheesemaker filed for Chapter 11 protection after listeria contamination left the company facing more than $74 million in legal liability.
September 22, 2025
Biotechnology company ProPhase Labs Inc. put three of its COVID-19 laboratory testing subsidiaries in Chapter 11 bankruptcy Monday in New Jersey with combined liabilities of more than $13 million, saying it has been underpaid by insurance companies.